The results showed that tumor specimens with higher ABCB1 expression (cases 3 and 4) displayed higher resistance to doxorubicin than that with lower ABCB1 expression (cases 1 and 2), which affirmed a clinical significance of ABCB1 in mediating MDR. Here, ABCB1 is linked to neoplasm.